These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8643559)

  • 1. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.
    Bernert H; Turski L
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists.
    Ikonomidou C; Turski L
    Metab Brain Dis; 1996 Jun; 11(2):125-41. PubMed ID: 8776715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain.
    Pohl D; Bittigau P; Ishimaru MJ; Stadthaus D; Hübner C; Olney JW; Turski L; Ikonomidou C
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2508-13. PubMed ID: 10051673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of trauma-induced neurodegeneration in infant rat brain.
    Ikonomidou C; Qin Y; Labruyere J; Kirby C; Olney JW
    Pediatr Res; 1996 Jun; 39(6):1020-7. PubMed ID: 8725264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.
    Diemer NH; Jørgensen MB; Johansen FF; Sheardown M; Honoré T
    Acta Neurol Scand; 1992 Jul; 86(1):45-9. PubMed ID: 1325729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
    Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
    Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C; Arvin B; Le Peillet E; Meldrum BS
    Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal death enhanced by N-methyl-D-aspartate antagonists.
    Ikonomidou C; Stefovska V; Turski L
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12885-90. PubMed ID: 11058158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam dependence prevented by glutamate antagonists.
    Steppuhn KG; Turski L
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6889-93. PubMed ID: 8341715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
    Lippert K; Welsch M; Krieglstein J
    Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-NMDA but not NMDA blockade at deep prepiriform cortex protects against hippocampal cell death in status epilepticus.
    Kawaguchi K; Simon RP
    Brain Res; 1997 Apr; 753(1):152-6. PubMed ID: 9125442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
    Wrathall JR; Teng YD; Choiniere D
    Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.